<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rbc China Equity Fund Class I — News on 6ix</title>
<link>https://6ix.com/company/rbc-china-equity-fund-class-i</link>
<description>Latest news and press releases for Rbc China Equity Fund Class I on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rbc-china-equity-fund-class-i" rel="self" type="application/rss+xml" />
<item>
<title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
<link>https://6ix.com/company/rbc-china-equity-fund-class-i/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-60</link>
<guid isPermaLink="true">https://6ix.com/company/rbc-china-equity-fund-class-i/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-60</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling</description>
</item>
<item>
<title>Waste Connections Reports First Quarter 2026 Results</title>
<link>https://6ix.com/company/rbc-china-equity-fund-class-i/news/waste-connections-reports-first-quarter-2026-results-5</link>
<guid isPermaLink="true">https://6ix.com/company/rbc-china-equity-fund-class-i/news/waste-connections-reports-first-quarter-2026-results-5</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>Better than expected Q1 results, with improving trends positioning for upside to 2026 outlook Revenue of $2.371 billion, above expectations and up 6.4% year</description>
</item>
</channel>
</rss>